These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Azotized emetine analogues: synthesis and evaluation of the anti-amebic and anti-tumoral action of aza-3 emetine and attempted synthesis of aza-2 emetine]. Gilbert J; Gansser C; Viel C; Cavier R; Chenu E; Hayat M Farmaco Sci; 1978 Apr; 33(4):237-52. PubMed ID: 216576 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and antileukemic activity of bis[[(carbamoyl)oxy]methyl]- substituted pyrrolo[2,1-a]isoquinolines, pyrrolo[1,2-a]quinolines, pyrrolo[2,1-a]isobenzazepines, and pyrrolo[1,2-a]benzazepines. Anderson WK; Heider AR; Raju N; Yucht JA J Med Chem; 1988 Nov; 31(11):2097-102. PubMed ID: 3184121 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological properties of new benz[h]isoquinoline derivatives. Janin YL; Carrez D; Riou JF; Bisagni E Chem Pharm Bull (Tokyo); 1994 Apr; 42(4):892-5. PubMed ID: 8020124 [TBL] [Abstract][Full Text] [Related]
5. Myxobacterial epothilones and tubulysins as promising anticancer agents. Dömling A; Richter W Mol Divers; 2005; 9(1-3):141-7. PubMed ID: 15789561 [TBL] [Abstract][Full Text] [Related]
6. [Tumor chemotherapy: synthesis of N-hydroxyethyl-isoquinoline-3-carboxylic lactone derivatives]. Yan XM; Weng ZY Yao Xue Xue Bao; 1985 Apr; 20(4):312-5. PubMed ID: 4072705 [No Abstract] [Full Text] [Related]
7. Synthesis of 1-(2-aminophenyl)isoquinolines and the biological activity of their cis-dichloro platinum(II) complexes. von Nussbaum F; Miller B; Wild S; Hilger CS; Schumann S; Zorbas H; Beck W; Steglich W J Med Chem; 1999 Sep; 42(18):3478-85. PubMed ID: 10479280 [TBL] [Abstract][Full Text] [Related]
8. 1H-pyrrolo[2,3-f]quinoline and isoquinoline derivatives: synthesis and antiproliferative activity. Ferlin MG; Chiarelotto G; Basadonna O; Gia O; Mobilio S; Baccichetti F; Carlassare F Farmaco; 1989 Dec; 44(12):1141-55. PubMed ID: 2634405 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and cytotoxic activity of 7-oxo-7H-dibenz[f,ij]isoquinoline and 7-oxo-7H-benzo[e]perimidine derivatives. Bu X; Deady LW; Finlay GJ; Baguley BC; Denny WA J Med Chem; 2001 Jun; 44(12):2004-14. PubMed ID: 11384245 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and antitumor activity of 4- and 5-substituted derivatives of isoquinoline-1-carboxaldehyde thiosemicarbazone. Liu MC; Lin TS; Penketh P; Sartorelli AC J Med Chem; 1995 Oct; 38(21):4234-43. PubMed ID: 7473550 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and murine antineoplastic activity of bis[(carbamoyloxy)methyl] derivatives of pyrrolo[2,1-a]isoquinoline. Anderson WK; McPherson HL; New JS; Rick AC J Med Chem; 1984 Oct; 27(10):1321-5. PubMed ID: 6481769 [TBL] [Abstract][Full Text] [Related]
12. [Synthesis and structure-activity relationship of N-(2-arylethyl) isoquinoline derivatives as anti-cancer agents]. Wang YX; Zhao WL; Bi CW; Li YB; Shao RG; Song DQ Yao Xue Xue Bao; 2012 Feb; 47(2):200-5. PubMed ID: 22512031 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, structure and antitumor activity of new benz[d,e]isoquinoline-1,3-diones. Braña MF; Castellano JM; Morán M; Emling F; Kluge M; Schlick E; Klebe G; Walker N Arzneimittelforschung; 1995 Dec; 45(12):1311-8. PubMed ID: 8595091 [TBL] [Abstract][Full Text] [Related]
14. Structural requirements for tumor-inhibitory activity among benzylisoquinoline alkaloids and related synthetic compounds. Kupchan SM; Altland HW J Med Chem; 1973 Aug; 16(8):913-7. PubMed ID: 4745835 [No Abstract] [Full Text] [Related]
15. Mutants of CHO cells resistant to the protein synthesis inhibitors, cryptopleurine and tylocrebrine: genetic and biochemical evidence for common site of action of emetine, cryptopleurine, tylocrebine, and tubulosine. Gupta RS; Siminovitch L Biochemistry; 1977 Jul; 16(14):3209-14. PubMed ID: 560858 [TBL] [Abstract][Full Text] [Related]
16. 6,9-Bis[(aminoalkyl)amino]benzo[g]isoquinoline-5,10-diones. A novel class of chromophore-modified antitumor anthracene-9,10-diones: synthesis and antitumor evaluations. Krapcho AP; Petry ME; Getahun Z; Landi JJ; Stallman J; Polsenberg JF; Gallagher CE; Maresch MJ; Hacker MP; Giuliani FC J Med Chem; 1994 Mar; 37(6):828-37. PubMed ID: 8145234 [TBL] [Abstract][Full Text] [Related]
17. Antitumor amino-substituted pyrido[3',4':4,5]pyrrolo[2,3-g]isoquinolines and pyrido[4,3-b]carbazole derivatives: synthesis and evaluation of compounds resulting from new side chain and heterocycle modifications. Rivalle C; Wendling F; Tambourin P; Lhoste JM; Bisagni E; Chermann JC J Med Chem; 1983 Feb; 26(2):181-5. PubMed ID: 6827534 [TBL] [Abstract][Full Text] [Related]
18. Anticancer activities of emetine prodrugs that are proteolytically activated by the prostate specific antigen (PSA) and evaluation of in vivo toxicity of emetine derivatives. Akinboye ES; Rosen MD; Bakare O; Denmeade SR Bioorg Med Chem; 2017 Dec; 25(24):6707-6717. PubMed ID: 29153549 [TBL] [Abstract][Full Text] [Related]
19. Structural determinants responsible for the biological activity of (-)-emetine, (-)-cryptopleurine, and (-)-tylocrebrine: structure-activity relationship among related compounds. Gupta RS; Krepinsky JJ; Siminovitch L Mol Pharmacol; 1980 Jul; 18(1):136-43. PubMed ID: 7412757 [No Abstract] [Full Text] [Related]
20. A novel synthesis of benzo[c]phenanthridine skeleton and biological evaluation of isoquinoline derivatives. Cho WJ; Park MJ; Imanishi T; Chung BH Chem Pharm Bull (Tokyo); 1999 Jun; 47(6):900-2. PubMed ID: 10399841 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]